Resultados de la búsqueda 21-30 of 4466 for treatment resistant depression
Inotuzumab Ozogamicin in Treating Younger Patients With Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia. Rochester, Minn. This phase II ...
... depression and anxiety. It has also been proposed ... This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy ...
The purpose of this study is to determine the effectiveness and safety of JCAR017 in adult subjects with relapsed or refractory Chronic Lymphocytic Leukemia ...
This study is being performed to understand the causes of drug resistance and to improve the treatment options for patients diagnosed with B-cell cancers.
Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery. Scottsdale/Phoenix, Ariz., ...
Authorizaton to Use Clincially Obtained Data for Research · Rare Kidney Stone Consortium Patient Registry · Post Approval Study for Treatment of Drug-resistant ...
... resistant or refractory ovarian cancer. Ascorbic Acid and Combination Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma or CCUS. Rochester ...
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
Deep brain stimulation of the medial forebrain bundle for treatment-resistant depression: A systematic review focused on the long-term antidepressive effect.
... resistant or refractory ovarian cancer. Circulating Tumor Nucleic Acids to Monitor Treatment Response in Metastatic Melanoma Patients. Scottsdale/Phoenix ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.